3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
9
Recruiting
3
Unknown
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
12
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
141
Precursor Cell Lymphoblastic Leukemia-Lymphoma
65
Hematologic Neoplasms
65
Leukemia
36
Leukemia, Lymphocytic, Chronic, B-Cell
34
Myelodysplastic Syndromes
24
Recurrence
23
Lymphoma
23
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
15
Neoplasms
14
Multiple Myeloma
9
Motor Activity
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasm, Residual
8
Lymphoma, Non-Hodgkin
8
Lymphoma, Follicular
8
Lymphoma, B-Cell
8
Leukemia, B-Cell
8
Lymphoma, Mantle-Cell
6
Burkitt Lymphoma
6
Myeloproliferative Disorders
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Plasma Cell
5
Leukemia, Myeloid, Chronic-Phase
5
Febrile Neutropenia
5
Waldenstrom Macroglobulinemia
4
Pain
4
Neoplasm Metastasis
4
Leukemia, Myelomonocytic, Chronic
4
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Laryngeal Neoplasms
×
Other hematologic neoplasm
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled